Skip to main content
logo
Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
1.150
-0.040 (-3.36%)
At close: Apr 7, 2026, 4:00 PM EDT
1.200
+0.050 (4.35%)
After-hours: Apr 7, 2026, 7:41 PM EDT

Fate Therapeutics Employees

Fate Therapeutics had 161 employees as of December 31, 2025. The number of employees decreased by 20 or -11.05% compared to the previous year.

Employees
161
Change (1Y)
-20
Growth (1Y)
-11.05%
Revenue / Employee
$41,280
Profits / Employee
-$846,677
Market Cap
133.70M

Employees Chart

Employees History

DateEmployeesChange (1Y)Growth (1Y)
Dec 31, 2025161-20-11.05%
Dec 31, 20241810-
Dec 31, 2023181-370-67.15%
Dec 31, 202255110222.72%
Dec 31, 202144917060.93%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Related Stocks

Company NameEmployees
Humacyte184
Molecular Partners AG134
Heron Therapeutics128
Cibus118
Immunic92
Tenaya Therapeutics70
Precision BioSciences68
Spero Therapeutics25
Employee Rankings

FATE News

More News